The eight main blood types are A+, A-, B+, B-, O+, O-, AB+, and AB-. The most common blood type in the United States is O-positive, with around 38 percent of the population having this type of blood. However, blood type O-positive is more common in Latino-Americans than other ethnicities, with around 53 percent of Latino-Americans with this blood type, compared to 47 percent of African Americans and 37 percent of Caucasians. Blood donation The American Red Cross estimates that every two seconds someone in the United States needs blood or platelets, highlighting the importance of blood donation. It was estimated that in 2021, around 6.5 million people in the U.S. donated blood, with around 1.7 million of these people donating for the first time. Those with blood type O-negative are universal blood donors, meaning their blood can be transfused for any blood type. Therefore, this blood type is the most requested by hospitals. However, only about seven percent of the U.S. population has this blood type. Blood transfusion Blood transfusion is a routine procedure that involves adding donated blood to a patient’s body. There are many reasons why a patient may need a blood transfusion, including surgery, cancer treatment, severe injury, or chronic illness. In 2021, there were around 10.76 million blood transfusions in the United States. Most blood transfusions in the United States occur in an inpatient medicine setting, while critical care accounts for the second highest number of transfusions.

The most common blood type among the population in the United States is O-positive. Around 53 percent of the Latino-American population in the U.S. has blood type O-positive, while only around 37 percent of the Caucasian population has this blood type. The second most common blood type in the United States is A-positive. Around 33 percent of the Caucasian population in the United States has A-positive blood type. Blood type O-negative Those with blood type O-negative are universal donors as this type of blood can be used in transfusions for any blood type. O-negative blood type is most common in the U.S. among Caucasian adults. Around eight percent of the Caucasian population has type O-negative blood, while only around one percent of the Asian population has this blood type. Only around seven percent of all adults in the United States have O-negative blood type. Blood Donations The American Red Cross estimates that someone in the United States needs blood every two seconds. However, only around three percent of age-eligible people donate blood yearly. The percentage of adults who donated blood in the United States has not fluctuated much for the past two decades. In 2021, around 15 percent of U.S. adults donated blood, the same share reported in the year 2003.

This statistic illustrates the distribution of blood groups in the French population, according to the Rhesus system. It shows that less than *** percent of French people had the blood group AB negative.

Blood type distribution of recipient according to blood type transfused JMC, southwest Ethiopia, February 1 to June 30, 2018 (n = 425).

In 2023, the most common blood type in South Korea was A-positive, with about 33.8 percent of the total blood donations. It was followed by O-positive and B-positive.

Percentages of blood groups (fi), susceptibility, , and inverse characteristic time, m, of the exponential phase of the infection for the analyzed countries as derived for the fit to the observed data.

According to Cognitive Market Research, the global blood group typing market size is USD XX million in 2023 and will expand at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2031.

The global blood group typing market will expand significantly by 8.8% CAGR between 2024 to 2031.
North America held the major market of more than XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Europe accounted for a share of over XX% of the global market size of USD XX million.
Asia Pacific held a market of around XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Latin America's market will have more than XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
Middle East and Africa held the major market of around XX% of the global revenue with a market size of USD XX million in 2023 and will grow at a compound annual growth rate (CAGR) of XX% from 2024 to 2031.
The blood group typing industry is set to rise due to increased blood group ownership rates, rising awareness regarding blood group health, accelerated R&D in the blood group typing industry, and the rise of E-commerce. Increasing online retail channels further bolster demand, while cultural significance and investment appeal contribute to its enduring popularity.
The blood group typing market is driven by rising awareness regarding blood group health, accelerated R&D in the blood group typing industry, and the rise of E-commerce.
Antibody Screenings are anticipated to form the majority of blood group owners in the years to come.

Current Scenario of the Blood Group Typing Market

Key Drivers of the Blood Group Typing Market

The growing incidence of chronic illnesses and the increase in surgical operations necessitates the need for blood donations

The demand for blood has grown as chronic diseases and the surgical procedures necessary to treat them have become more common. Blood transfusions are typically necessary for patients with chronic illnesses to manage their symptoms, and large volumes of blood are required for surgical procedures, particularly major surgeries, to ensure safe and effective results. As a result, the need for blood has steadily increased within the healthcare system, which has led to a rise in blood donation rates. The market is anticipated to benefit from this. To treat patients with chronic illnesses and those having difficult surgical operations, the American National Red Cross (2023) estimates that every day, over 29,000 units of red blood cells are required in US hospitals and emergency rooms. For instance, according to the National Center for Biotechnology Information, the number of people 50 years of age and older who have at least one chronic illness is predicted to rise from 71.522 million in 2020 to 142.66 million in 2050, a 99.5% increase.

Source- https://pubmed.ncbi.nlm.nih.gov/36711415/#:~:text=Of%20the%20population%2050%20years,to%2014.968%20million%20in%202050.

Blood group typing is a necessary test that establishes the Rh factor and the level of blood compatibility between the donor and the recipient prior to blood transfusions. Thus, the need for blood donations is a result of the rising prevalence of chronic illnesses and the rise in surgical procedures.

Blood Donation rates have necessitated the need for Blood Group Typing

Global blood donation rates have significantly increased over time. The need for transfusion procedures such as blood type detection and cross-matching has surged due to a rise in voluntary blood donations. The National Health Service Blood and Transplant (NHSBT) receives over 1.5 million voluntary blood donations annually, which are processed by the government before being given to hospitals and patients in need, according to an article published by the European Blood Alliance (EBA) (2019–2022).

Source- https://www.nhsbt.nhs.uk/who-we-are/a-history-of-donation-transfusion-and-transplantation/

NHSBT supplies hospitals in England with a secure and dependable supply of blood components, diagnostic services, and stem cell treatments. To do this, it depends on 1...

The dataset titled "Number of Blood Bags Delivered by Blood Bank of Hamad Medical Corporation by Blood Group" provides annual data on the number of blood bags delivered by the Hamad Medical Corporation's blood bank from . The data is categorized by blood group (A-, A+, AB-, AB+, B-, B+, O-, O+, and Rare Blood Group). This dataset is valuable for understanding the distribution of blood types and the demand for specific blood groups in Qatar, supporting healthcare planning and blood supply management.

Data used to determine the quantities plotted in Figs 2 and 3: ln(di/fi) and , with di being the fractions of infected having blood group i, fi is the fraction of population with blood group i and represent the susceptibility of the population to become infected.

In 2022, almost ** percent of organ donors who donated in Italy had type O blood, while **** percent had type A. This statistic displays the distribution of organ donors in Italy in 2022, by blood type.

Cases and controls blood group distribution for study subgroup.

The global blood group typing market is experiencing robust growth, driven by the increasing prevalence of blood transfusions and the rising demand for accurate and rapid blood typing methods. Technological advancements, such as the adoption of automated and high-throughput systems, are significantly improving the efficiency and accuracy of blood typing procedures, leading to faster turnaround times and reduced errors. Furthermore, the growing prevalence of chronic diseases requiring frequent blood transfusions and the increasing number of surgical procedures are contributing to market expansion. The market is segmented by type (manual, automated) and application (blood banks, hospitals, research). The automated segment is witnessing rapid growth due to its advantages in speed, accuracy, and efficiency. Hospitals and blood banks constitute the largest application segments, driven by their high volume of blood typing needs. Key players such as Agena Bioscience, Bio-Rad Laboratories, Danaher, Merck KGaA, and Ortho Clinical Diagnostics are strategically investing in research and development, mergers and acquisitions, and geographical expansion to solidify their market positions. This competitive landscape is fostering innovation and leading to the development of advanced blood typing technologies. The market's geographical distribution demonstrates significant regional variations. North America and Europe currently hold the largest market shares, attributed to well-established healthcare infrastructure, high adoption rates of advanced technologies, and increasing healthcare expenditure. However, developing economies in Asia-Pacific and the Middle East & Africa are exhibiting promising growth potential due to rising healthcare awareness, improving healthcare infrastructure, and increasing government initiatives aimed at enhancing healthcare services. While the market faces challenges such as stringent regulatory requirements and high costs associated with advanced technologies, the overall growth trajectory remains positive, fueled by unmet needs for efficient and precise blood typing solutions. We project sustained market expansion over the forecast period, driven by continued technological innovation and increasing healthcare demands globally.

As of 2020, the most common blood type among tested donors in Brazil was O+, with **** percent of the total. A+ followed, with ** percent of tested donors. The least common blood type among donors in Brazil was AB-. That year, the rate of blood donors in Brazil amounted to ***** per 1,000 inhabitants.

Complete blood count of the household population, by sex and age group.

NHS = Nurses' Health Study, HPFS = Health Professionals Follow-up Study.

The global ABO blood typing test kit market is experiencing robust growth, driven by rising prevalence of blood transfusions, increasing incidence of blood-related disorders, and expanding diagnostic testing capabilities in both developed and developing nations. The market, currently estimated at $1.5 billion in 2025, is projected to exhibit a Compound Annual Growth Rate (CAGR) of 7% from 2025 to 2033, reaching a value exceeding $2.5 billion by the end of the forecast period. This expansion is fueled by technological advancements leading to faster, more accurate, and automated testing methods. The increasing adoption of point-of-care testing (POCT) devices contributes significantly to market growth, allowing for rapid blood type determination in various settings, including emergency rooms and remote areas. Furthermore, stringent regulatory frameworks promoting blood safety and the growing awareness of the importance of accurate blood typing before transfusions are key market drivers. The market is segmented by application (hospital, clinic) and type of test kit (positive stereotype, anti-stereotype), with hospitals currently dominating the application segment due to higher testing volumes. Geographic growth is expected to be fairly evenly distributed across regions, with North America and Europe maintaining substantial market shares due to established healthcare infrastructure and high healthcare expenditure. However, rapidly developing economies in Asia-Pacific, particularly China and India, are poised for significant market expansion, driven by growing healthcare investments and increasing adoption of advanced diagnostic technologies. Competition is moderate, with several key players vying for market share. The market faces challenges including the high cost of advanced testing kits and the potential for errors in manual testing procedures. However, ongoing research and development efforts are focused on mitigating these challenges through the introduction of cost-effective and highly accurate automated systems. The prevalence of infectious diseases also presents a constraint, as meticulous safety measures are essential during blood typing procedures. Despite these challenges, the long-term outlook for the ABO blood typing test kit market remains positive, propelled by sustained demand for accurate and rapid blood typing, expanding healthcare infrastructure globally, and the continuous development of innovative testing technologies. The market's growth trajectory underscores the critical role of accurate blood typing in ensuring safe and effective blood transfusions and overall patient care.

The global ABO blood group reagent market is experiencing steady growth, projected to reach a market size of $1.2 Billion by 2025, exhibiting a Compound Annual Growth Rate (CAGR) of 5%. This growth is driven by several key factors, including the rising prevalence of blood-related diseases and increasing demand for accurate and reliable blood typing in hospitals and blood banks worldwide. Advancements in reagent technology, leading to improved accuracy and efficiency, further contribute to market expansion. The positive identification segment dominates the market due to its widespread use in routine blood testing procedures. However, the reverse identification segment is also witnessing substantial growth, driven by the increasing need for confirmatory testing and improved diagnostic accuracy in complex cases. Geographic distribution reveals strong market presence in North America and Europe, driven by well-established healthcare infrastructure and higher adoption rates of advanced technologies. However, the Asia-Pacific region is anticipated to show significant growth potential in the forecast period (2025-2033), fueled by increasing healthcare spending and rising awareness regarding blood safety. While the market faces certain restraints such as stringent regulatory approvals and the availability of cost-effective alternatives, the overall positive outlook remains driven by consistent demand for accurate and efficient blood typing solutions. The market segmentation by application reveals that hospitals and blood banks are the largest consumers of ABO blood group reagents, reflecting their critical role in ensuring blood safety and transfusion compatibility. The research segment is also experiencing growth as research institutions increasingly use these reagents in various studies and developments related to blood groups. Key players in the market, such as CE-Immundiagnostika GmbH, Dominion Biologicals Limited, and SHPBC, are focused on product innovation and strategic partnerships to maintain market competitiveness. The market is further shaped by regional differences in healthcare infrastructure, regulatory landscape, and disease prevalence, impacting the regional distribution of market share. Future growth is expected to be influenced by technological advancements, evolving regulatory frameworks, and increased investment in healthcare infrastructure across emerging economies.

Demographic and clinical data of blood transfusion recipients according to their sex at JMC, southwest Ethiopia, February 1 to June 30, 2018 (n = 425).

The Blood Group Plate market has emerged as a critical niche within the healthcare and diagnostics sector, catering to the growing need for efficient blood typing and compatibility testing. These plates play an essential role in transfusion medicine by aiding in the rapid identification of blood groups and ensuring

The global market for glass bead blood group test cards is experiencing robust growth, driven by the increasing prevalence of blood transfusion-related diseases and the rising demand for accurate and rapid blood typing in hospitals, research centers, and laboratories worldwide. The market's expansion is further fueled by technological advancements leading to more efficient and user-friendly test cards, coupled with a growing preference for point-of-care testing. This shift towards faster diagnostic tools minimizes turnaround times and enhances patient care, particularly in resource-constrained settings. The market is segmented by application (hospitals, research centers, laboratories, and others) and by type of test (blood grouping forward and reverse tests, cross-match tests, and others). Hospitals currently dominate the market share, owing to their high volume of blood transfusions. However, the research and laboratory segments are expected to witness significant growth in the coming years, driven by increasing research activities in hematology and immunology. While the market faces challenges such as stringent regulatory approvals and the potential for errors in manual testing procedures, ongoing innovations focused on automation and quality control measures are mitigating these risks. The competitive landscape is characterized by a mix of established global players and regional manufacturers, leading to a dynamic market environment. Based on a projected CAGR (let's assume a conservative 7% for illustration—this should be replaced with the actual CAGR from your data), and a 2025 market size (let's assume $500 million for illustration—again, replace with your data), the market is poised for considerable expansion through 2033. Geographical distribution shows a significant market share held by North America and Europe, due to established healthcare infrastructure and high adoption rates. However, developing regions in Asia-Pacific and the Middle East & Africa are witnessing rapid growth, fuelled by improving healthcare access and rising disposable incomes. This signifies substantial growth opportunities for both established and emerging market players in these regions. The market's future trajectory suggests continued growth driven by technological enhancements, increasing healthcare expenditure, and evolving diagnostic practices globally.